Uroplasty, Inc Report issue

For profit Phase 4
Founded: Minnetonka MN United States (1992)
Status: Acquired by Cogentix Medical (2014) → now Laborie Medical Technologies (2018)

Organization Overview

First Clinical Trial
2006
NCT00448175
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (1)

tolterodine (detrol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Urinary Bladder, Overactive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1